Evidence map›Paper›PMID 21228272›Full record

ArticleThe Journal of biological chemistry2011

FXYD proteins stabilize Na,K-ATPase: amplification of specific phosphatidylserine-protein interactions.

Neeraj Kumar Mishra, Yoav Peleg, Erica Cirri, Talya Belogus, Yael Lifshitz, Dennis R Voelker, Hans-Juergen Apell, Haim Garty, Steven J D Karlish

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Active conformations of neuronal NaNature communications · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The NaFrontiers in endocrinology · 2023
    Review
  9. Displacement of Native FXYD Protein From NaFrontiers in oncology · 2022
    Article
  10. Article
  11. What FXYDs fix.The Journal of general physiology · 2021
    Article
  12. NaMolecules (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Genetics of Magnesium Disorders.Kidney diseases (Basel, Switzerland) · 2017
    Review
  20. Phospholemman, a major regulator of skeletal muscle NaExperimental and therapeutic medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Neeraj Kumar MishraDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovoth 76100, Israel.
Yoav Peleg
Erica Cirri
Talya Belogus
Yael Lifshitz
Dennis R Voelker
Hans-Juergen Apell
Haim Garty
Steven J D Karlish
University of Konstanz · DEWeizmann Institute of Science · ILNational Jewish Health · US

Funding

Phospholipid Dynamics in Membrane AssemblyR37GM032453 · NIGMS · NATIONAL JEWISH HEALTH · PI VOELKER, DENNIS R. · 2003 to 2012
$3.7M
Novel Roles for Lysophospholippids in Eukaryotic Membrane Biogenesis and TurnoverR01GM081461 · NIGMS · NATIONAL JEWISH HEALTH · PI VOELKER, DENNIS R. · 2008 to 2011
$1.2M
NIGMS NIH HHS 5R37-GM32453NIGMS NIH HHS GM081461NIGMS NIH HHS R01 GM081461NIGMS NIH HHS R37 GM032453
6 · The paper itself

Abstract

FXYD proteins are a family of seven small regulatory proteins, expressed in a tissue-specific manner, that associate with Na,K-ATPase as subsidiary subunits and modulate kinetic properties. This study describes an additional property of FXYD proteins as stabilizers of Na,K-ATPase. FXYD1 (phospholemman), FXYD2 (γ subunit), and FXYD4 (CHIF) have been expressed in Escherichia coli and purified. These FXYD proteins associate spontaneously in vitro with detergent-soluble purified recombinant human Na,K-ATPase (α1β1) to form α1β1FXYD complexes. Compared with the control (α1β1), all three FXYD proteins strongly protect Na,K-ATPase activity against inactivation by heating or excess detergent (C(12)E(8)), with effectiveness FXYD1 > FXYD2 ≥ FXYD4. Heating also inactivates E(1) ↔ E(2) conformational changes and cation occlusion, and FXYD1 protects strongly. Incubation of α1β1 or α1β1FXYD complexes with guanidinium chloride (up to 6 m) causes protein unfolding, detected by changes in protein fluorescence, but FXYD proteins do not protect. Thus, general protein denaturation is not the cause of thermally mediated or detergent-mediated inactivation. By contrast, the experiments show that displacement of specifically bound phosphatidylserine is the primary cause of thermally mediated or detergent-mediated inactivation, and FXYD proteins stabilize phosphatidylserine-Na,K-ATPase interactions. Phosphatidylserine probably binds near trans-membrane segments M9 of the α subunit and the FXYD protein, which are in proximity. FXYD1, FXYD2, and FXYD4 co-expressed in HeLa cells with rat α1 protect strongly against thermal inactivation. Stabilization of Na,K-ATPase by three FXYD proteins in a mammalian cell membrane, as well the purified recombinant Na,K-ATPase, suggests that stabilization is a general property of FXYD proteins, consistent with a significant biological function.

Indexed as

Protein FoldingAnimalsHeLa CellsHot TemperatureHumansMembrane ProteinsMultiprotein ComplexesPhosphatidylserinesPhosphoproteinsRatsSodium-Potassium-Exchanging ATPaseMembrane ProteinsMultiprotein ComplexesPhosphatidylserinesPhosphoproteinsSodium-Potassium-Exchanging ATPase

Identifiers

PMID21228272
PMCPMC3058982
OpenAlexW1964490122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.